Home › Products › Oncology › Femmeola 150mg Tablet 60's

Femmeola 150mg Tablet 60's

Salt Composition: OLAPARIB

₹12375.00₹23625.00

Inclusive of all taxes

Categories: Oncology

Conditions: Anti Cancer

Product Introduction

Femmeola Tablet is a PARP (poly[adenosine diphosphate-ribose] polymerase inhibitor) class cancer medication containing the active ingredient Olaparib. It is used to treat pancreatic and prostate cancer. This medication may be administered as monotherapy or in combination with other anticancer drugs. Olaparib should not be used if you are allergic to the active ingredient or any other component of the medicine. Contact your doctor immediately if you develop breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will perform blood tests before treatment initiation and monthly during treatment, as this medicine may reduce red blood cell, white blood cell, and platelet counts. Inform your healthcare provider before starting treatment if you have been diagnosed with lung, liver, heart, or kidney disorders. This medication is not advised during pregnancy as it may cause fetal harm and miscarriage. Women of reproductive potential should undergo pregnancy testing before beginning this medication. Continued use of contraception is recommended for at least six months after treatment completion. Breastfeeding is not advised during treatment as it is unknown whether Femmeola Tablet passes into breast milk. Men should not donate sperm for at least 3 months after treatment completion. Inform your doctor of all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and supplements.

Uses

Treatment of Prostate cancer Metastatic Pancreatic cancer

How it works

Ribaxa Plus 100mg tablet works by inhibiting the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells. By inhibiting PARP, Femmeola Tablet prevents cancer cells from repairing their DNA, leading to cell death. This targeted approach is especially effective in cancers with defective DNA repair mechanisms.

How to Use

A healthcare professional will prescribe the medicine to you in a hospital setting. Femmeola Tablet can be taken with or without food, as directed by your healthcare provider. The dose will be decided by your healthcare professional based on your conditions. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Femmeola Tablet at the same time every day.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Neutropenia Acute myeloid leukemia Leukopenia Thrombocytopenia Lung problems Common Shortness of breath Nausea Vomiting Fatigue Dyspepsia Loss of appetite Dizziness Diarrhoea Headache

Expert Tips

Femmeola Tablet can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Femmeola Tablet should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Femmeola 150mg Tablet 60's. Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, Obrenza 100mg Tablet can be an effective treatment option for certain types of cancer.

References

  1. Lynparza, United States Food and Drug Administration (USFDA), [Revised on May 2020], [Accessed on March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208558s014lbl.pdf
  2. AstraZeneca UK Limited, European Medicines Compendium (emc), [Revised on August 2023], [Accessed on March 2024], https://www.medicines.org.uk/emc/files/pil.9204.pdf
  3. AstraZeneca Pharmaceuticals LP, [Revised on November 2023], [Accessed on March 2024], https://den8dhaj6zs0e.cloudfront.net/50fd68b9-106b-4550-b5d0-12b045f8b184/00997c3f-5912-486f-a7db-930b4639cd51/00997c3f-5912-486f-a7db-930b4639cd51_viewable_rendition__v.pdf

Safety Advice

Pregnancy: unsafe It is not recommended to take Femmeola Tablet during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.

Lungs: Consult your doctor Consult your doctor if you have any lung diseases before starting the treatment with Femmeola Tablet.

Breastfeeding: unsafe It is unknown whether Femmeola Tablet passes into the breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy. Please consult your doctor before breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS